|
Real-time Estimate
Cboe BZX
05:59:50 09/09/26 am AEST
|
5-day change | 1st Jan Change | ||
| 22.94 USD | -1.04% |
|
+0.44% | -13.89% |
| 19/08 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 07/08 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
| Market Cap | 986M 848M 798M 728M 1.36B 93.48B 1.37B 9.45B 3.66B 47.78B 3.7B 3.62B 152B | P/E 2026 * |
10.7x | P/E 2027 * | 8.78x |
|---|---|---|---|---|---|
| Enterprise Value | 1.29B 1.11B 1.04B 952M 1.78B 122B 1.79B 12.36B 4.78B 62.48B 4.84B 4.74B 199B | EV / Sales 2026 * |
1.72x | EV / Sales 2027 * | 1.49x |
| Free-Float |
47.23% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMPH | Delayed | |
CBOE
| AMPH | Real-time | |
|
Tradegate
| 29A | Real-time | |
|
Deutsche Boerse AG
| 29A | Delayed | |
|
Börse Stuttgart
| 29A | Delayed | |
|
Boerse Muenchen
| 29A | Real-time |
Last Transcript : Amphastar Pharmaceuticals, Inc.
| 1 day | -0.52% | ||
| 1 week | +0.44% | ||
| Current month | +2.35% | ||
| 1 month | +13.54% | ||
| 3 months | +18.93% | ||
| 6 months | +20.04% | ||
| Current year | -13.89% |
| 1 week | 22.3 |  | 23.92 |
| 1 month | 19.55 | | 23.92 |
| Current year | 16.64 | | 29.52 |
| 1 year | 16.64 | | 29.52 |
| 3 years | 16.64 | | 65.92 |
| 5 years | 16.64 | | 67.66 |
| 10 years | 12.05 | | 67.66 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Feng Zhang
CEO | Chief Executive Officer | 79 | 29/02/1996 |
Zi Ping Luo
COO | Chief Operating Officer | 76 | 29/02/1996 |
William Peters
DFI | Director of Finance/CFO | 58 | 01/04/2014 |
| Director | Title | Age | Since |
|---|---|---|---|
Zi Ping Luo
CHM | Chairman | 76 | 29/02/1996 |
Yong Feng Zhang
BRD | Director/Board Member | 79 | 29/02/1996 |
William Peters
BRD | Director/Board Member | 58 | 04/08/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/9/26 | Sell | Chief Technology Officer | -3,187 | 0.0075% | ||
| 11/8/26 | Sell | Director | -7,973 | 0.0181% | ||
| 7/8/26 | Exercice | Chief Financial Officer | 18,286 | 0.0415% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.04% | +0.44% | -21.19% | -53.89% | 986M | |
| -1.98% | -3.38% | +51.74% | +91.12% | 1,024B | |
| -1.97% | -0.70% | +51.18% | +67.73% | 663B | |
| -3.04% | -4.08% | +18.87% | +67.35% | 453B | |
| -0.88% | -0.65% | +27.83% | +36.57% | 349B | |
| -10.89% | -9.30% | +7.52% | +26.14% | 295B | |
| -1.38% | -0.79% | -1.77% | +9.72% | 253B | |
| -10.31% | -10.61% | +39.77% | +50.96% | 236B | |
| -2.32% | -0.14% | -16.57% | -56.82% | 206B | |
| -2.62% | -2.34% | +26.35% | +92.65% | 187B | |
| Average | -3.51% | +1.44% | +18.37% | +33.15% | 366.83B | |
| Weighted average by Cap. | -3.15% | +0.42% | +32.14% | +57.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 748M 643M 605M 552M 1.03B 70.89B 1.04B 7.17B 2.77B 36.23B 2.81B 2.75B 115B | 784M 674M 634M 579M 1.08B 74.36B 1.09B 7.52B 2.91B 38.01B 2.95B 2.88B 121B |
| Net income | 99.32M 85.39M 80.34M 73.32M 137M 9.42B 138M 952M 368M 4.81B 373M 365M 15.31B | 115M 99.24M 93.36M 85.2M 159M 10.94B 160M 1.11B 428M 5.59B 433M 424M 17.8B |
| Net Debt | 303M 261M 245M 224M 418M 28.77B 420M 2.91B 1.13B 14.7B 1.14B 1.11B 46.79B | 184M 158M 149M 136M 254M 17.46B 255M 1.76B 683M 8.92B 691M 676M 28.39B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | USD 22.97 | -0.91% | 293,560 |
| 04/09/26 | USD 23.18 | -2.77% | 650,129 |
| 03/09/26 | USD 23.84 | +0.42% | 469,751 |
| 02/09/26 | USD 23.74 | +3.40% | 456,779 |
| 01/09/26 | USD 22.96 | +1.91% | 550,979 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMPH Stock
Select your edition
All financial news and data tailored to specific country editions
